Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
2.
Int J STD AIDS ; 32(14): 1354-1357, 2021 12.
Article in English | MEDLINE | ID: mdl-34284668

ABSTRACT

Condyloma lata, a cutaneous manifestation of secondary syphilis, typically presents as verrucous papules or plaques in the anogenital area. Here, we present a case of secondary syphilis presenting in a 38-year-old man as condyloma latum of the plantar foot in the absence of other cutaneous findings of secondary syphilis. The plantar foot is an unusual location for condyloma lata which has not previously been reported in the medical literature. Histopathology was essential to diagnosis in this case and demonstrated verrucous epidermal hyperplasia with a plasma cell-rich infiltrate in the dermis and innumerable spirochetes in the epidermis. The patient was successfully treated with intramuscular penicillin benzathine G. Given the recent rise in the incidence of primary and secondary syphilis, it is essential for clinicians to be aware of atypical presentations of secondary syphilis to avoid delays in treatment and decrease the risk of transmission to sexual partners.


Subject(s)
Condylomata Acuminata , Syphilis, Cutaneous , Syphilis , Adult , Condylomata Acuminata/complications , Condylomata Acuminata/diagnosis , Condylomata Acuminata/drug therapy , Humans , Male , Penicillin G Benzathine/therapeutic use , Syphilis/complications , Syphilis/diagnosis , Syphilis/drug therapy , Syphilis, Cutaneous/diagnosis
4.
Int J STD AIDS ; 31(10): 1004-1007, 2020 09.
Article in English | MEDLINE | ID: mdl-32693735

ABSTRACT

Nodular secondary syphilis is an uncommon variant of secondary syphilis. We identified three cases of nodular secondary syphilis at our institution. The first patient presented with a diffuse nodular rash that included his scrotum and penis. The second patient had disseminated skin-colored nodules with serosanguinous crust on his face, trunk, and extremities. The third patient had a pruritic papular and nodular rash with overlying crust. All three patients had a reactive rapid plasma reagin and tested positive for fluorescent treponemal antibody absorption. All were eventually confirmed to be human immunodeficiency virus-positive. Histopathological examination demonstrated inflammatory infiltrate in the dermis composed of lymphocytes, histiocytes, and plasma cells, and treponemal staining highlighted spirochetes in the dermis. The patients were successfully treated with intramuscular penicillin benzathine G. Physicians should be aware of nodular syphilis as a less common cutaneous manifestation of secondary syphilis. Prompt diagnosis of secondary syphilis can expedite resolution of the infection and avoid progression to tertiary syphilis.


Subject(s)
HIV Seropositivity/complications , Penicillin G Benzathine/therapeutic use , Syphilis/drug therapy , Treponema pallidum/isolation & purification , Adult , Exanthema/pathology , Humans , Male , Penicillin G Benzathine/administration & dosage , Syphilis/diagnosis , Syphilis Serodiagnosis , Syphilis, Cutaneous/pathology , Treatment Outcome , Treponema pallidum/immunology
5.
Dermatol Online J ; 25(7)2019 Jul 15.
Article in English | MEDLINE | ID: mdl-31450276

ABSTRACT

Follicular porokeratosis is a rare variant of porokeratosis in which the coronoid lamellae are confined to hair follicles. It classically presents with annular plaques with a surrounding keratotic ridge. However, the clinical presentation has shown significant variation in reported cases. We present the case of a 26-year-old man with chronic diffuse follicular spicules associated with alopecia. Clinical findings were suggestive of trichodysplasia spinulosa, but multiple biopsies showed findings consistent with follicular porokeratosis. Diffusely spiculated presentation as present in our patient has not been previously reported in the literature. It is important to recognize the necessity of histopathologic confirmation in a diagnostically challenging condition such as follicular porokeratosis.


Subject(s)
Hair Follicle/pathology , Porokeratosis/pathology , Adult , Alopecia/pathology , Biopsy , Humans , Male , Porokeratosis/complications , Sturge-Weber Syndrome/complications
6.
Dermatol Online J ; 25(12)2019 Dec 15.
Article in English | MEDLINE | ID: mdl-32045166

ABSTRACT

Verrucous venous malformation, also known as verrucous hemangioma, is a superficial vascular malformation with a variable degree of hyperkeratosis that is composed of capillaries and veins in the dermis and sometimes subcutaneous tissue. We describe a 53-year-old man who presented with a large hyperkeratotic plaque of the left dorsal and plantar foot. Biopsy revealed verrucous acanthosis of the epidermis and a proliferation of thin-walled vessels in the dermis. We provide a brief review of the clinical and histopathologic presentation, differential diagnosis, and management of this rare entity.


Subject(s)
Foot Diseases/pathology , Foot/pathology , Hemangioma/pathology , Biopsy , Diagnosis, Differential , Hemangioma/diagnosis , Hemangioma/therapy , Humans , Male , Middle Aged
7.
Medicine (Baltimore) ; 97(40): e12436, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30290600

ABSTRACT

Nocardia is a ubiquitous environmental pathogen that causes infection primarily following inhalation into the lungs. It is generally thought to cause infection primarily in immunocompromised patients, but nonimmunocompromised individuals are also at risk of infection. We sought to compare risk factors, clinical manifestations, diagnostic approach, treatment, and mortality in immunocompromised and nonimmunocompromised adults with nocardiosis.We studied all adults with culture-proven Nocardia infection at a tertiary care hospital from 1994 to 2015 and compared immunocompromised with nonimmunocompromised patients. The immunocompromised group included patients who had a solid organ transplant, hematopoietic cell transplant (HCT), hematological or solid tumor malignancy treated with chemotherapy in the preceding 90 days, inherited immunodeficiency, autoimmune/inflammatory disorders treated with immunosuppressive agents, or high-dose corticosteroid therapy for at least 3 weeks before the diagnosis of nocardiosis.There were 112 patients, mean age 55 ±â€Š17 years; 54 (48%) were women. Sixty-seven (60%) were immunocompromised, and 45 (40%) were nonimmunocompromised. The lung was the site of infection in 54 (81%) immunocompromised and 25 (55%) nonimmunocompromised patients. Pulmonary nocardiosis in immunocompromised patients was associated with high-dose corticosteroids, P = .002 and allogeneic HCT, P = .01, and in nonimmunocompromised patients with cigarette smoking, bronchiectasis, and other chronic lung diseases, P = .002.Cavitation occurred only in the immunocompromised group, P < .001. Disseminated infection was more common in the immunocompromised, P = .01, and was highest in solid organ transplant recipients, P = .007. Eye infection was more common in nonimmunocompromised patients, P = .009. Clinical signs and symptoms did not differ significantly between the 2 groups. The initial treatment for most patients in both groups was trimethoprim-sulfamethoxazole with or without a carbapenem. All-cause 1-year mortality was 19%; 18 (27%) immunocompromised and 3 (7%) nonimmunocompromised patients died, P = .01.Immunocompromised patients with nocardiosis had more severe disease and significantly higher mortality than nonimmunocompromised patients, but clinical presentations did not differ.


Subject(s)
Eye Infections, Bacterial/immunology , Immunocompromised Host , Lung Diseases/immunology , Nocardia Infections/immunology , Nocardia/immunology , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Carbapenems/therapeutic use , Drug Therapy, Combination , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/mortality , Female , Humans , Lung Diseases/microbiology , Lung Diseases/mortality , Male , Middle Aged , Nocardia Infections/microbiology , Nocardia Infections/mortality , Retrospective Studies , Risk Factors , Transplantation/adverse effects , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...